Richard Babkes is a Neurologist in Ellicott City, Maryland. Dr. Babkes is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Essential Tremor, Peripheral Neuropathy, Neuralgia, and Dravet Syndrome.

Marcelino Albuerne is a primary care provider, practicing in Family Medicine in Catonsville, Maryland. Dr. Albuerne is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Glycine Encephalopathy, Anemia, Familial Hypertension, Gastrostomy, and Endoscopy.

Zhaoming Chen is a Neurologist in Baltimore, Maryland. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Periodic Limb Movement Disorder, and Peripheral Neuropathy.

Dr. Haris Sair is Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, and the Director of the Division of Neuroradiology. His areas of clinical expertise include functional Magnetic Resonance Imaging (fMRI) of the brain. He also has a faculty appointment in the Malone Center for Engineering in Healthcare at The Whiting School of Engineering, Johns Hopkins University, investigating the use of machine learning and artificial intelligence in imaging. He is a founding director of the Radiology Artificial Intelligence Lab (RAIL). He previously served as the President of the American Society of Functional Neuroradiology. Dr. Sair earned his M.D. from Duke University School of Medicine. He completed his Radiology residency at Temple University Medical Center, and fellowship in Neuroradiology at Massachusetts General Hospital in Boston, MA. Dr. Sair is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Hydrocephalus, Normal Pressure Hydrocephalus, Traumatic Brain Injury, Cerebrospinal Fluid Leak, and Microvascular Decompression.

Dr. Becker is a neurologist who earned his Medical Degree from Ruprecht Karls University in Heidelberg, Germany in 2001. From 2001 to 2003, he was a Research Assistant in Neuroscience investigating the role of embryonic stem cells in spinal cord injury repair at Washington University School of Medicine in St. Louis, Missouri. At Vanderbilt University Medical Center in Nashville, Tennessee, he completed his residency in Internal Medicine in 2004 and his residency in Neurology in 2007. From there, he completed a year-long fellowship in Spinal Cord Injury Medicine at the Johns Hopkins School of Medicine in Baltimore, MD. Dr. Becker is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Multiple Sclerosis (MS), Paraplegia, Relapsing Multiple Sclerosis (RMS), and Cerebellar Multiple System Atrophy.

Merrill Ansher is a Neurologist in Columbia, Maryland. Dr. Ansher is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Seizures, Familial Neurocardiogenic Syncope, Delirium, and Generalized Tonic-Clonic Seizure.

Dr. Esther Oh is a Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise is in evaluation and management of memory disorders. She has an extensive experience in evaluating memory disorders in older adults with multiple chronic diseases, and takes and integrative approach in the treatment of memory disorders. Dr. Oh also serves as the co-director of the Johns Hopkins Memory and Alzheimer’s Treatment Center. Dr. Oh earned her M.D. from the UHS/Chicago Medical School. She completed her residency in internal medicine at the University of Illinois at Chicago where she was a chief resident. She completed a fellowship in geriatric medicine and gerontology at Johns Hopkins University School of Medicine, and received her Ph.D. from the Johns Hopkins Bloomberg School of Public Health. Dr. Oh has received numerous awards including the Merck New Investigator Award, AFAR New Investigator Award in Alzheimer’s disease, and the Johns Hopkins Clinical Research Scholars Award. She is also a recipient of several major grants from the National Institute on Aging (NIA). She has also been honored for her teaching by Excellence in Teaching Award in the Division of Geriatric Medicine and Gerontology in 2013 and 2017. Dr. Oh’s research is primarily focused on Alzheimer’s disease and related disorders. Her current projects include: development of biomarkers for detecting early stages of Alzheimer’s disease; understanding the interrelationship between delirium and Alzheimer’s disease; cognitive changes after surgery; and understanding the role of sensory problems (hearing and vestibular function) in Alzheimer’s disease. Dr. Oh is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. Her top areas of expertise are Delirium, Alzheimer's Disease, Dementia, Deep Brain Stimulation, and Liver Transplant.

1988-1992, Assistant Professor, Department of Pharmacology, Semmelweis Medical University, Budapest, Hungary. 1992-1996, Instructor, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 2001-2014, Assistant Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2012-2014, Assistant Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Associate Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. Dr. Yasar is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. Her top areas of expertise are Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Dementia, and Alzheimer's Disease.

Milap Nowrangi, M.D., MS, is an assistant professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine. Dr. Nowrangi specializes in the diagnosis and treatment of age-related cognitive disorders, including Alzheimer's Disease and related dementias. He also is interested in the treatment or management of behavioral and cognitive sequelae of neurological diseases, including those caused by traumatic brain injury, stroke, epilepsy or toxic exposures. Dr. Nowrangi is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Alzheimer's Disease, Dementia, Bipolar Disorder (BPD), and Neuronal Intranuclear Inclusion Disease (NIID).

A native of Athens, Greece, Professor Lyketsos graduated from Northwestern University with a BA in Psychology and from Washington University Medical School in St. Louis with a Medical Doctorate. He completed residency and Chief Residency in psychiatry at Johns Hopkins, as well as a fellowship in clinical epidemiology. An active clinician, teacher, and researcher, Dr. Lyketsos is a world expert in the care and treatment of patients with Alzheimer’s and related dementias (ADRD). He carried out pioneering work on the epidemiology and treatment of neuropsychiatric features of AD. His team is developing biomarkers to accelerate treatment development for AD while designing and implementing innovative clinical trials. He leads efforts to ensure the provision of state-of-the-art Dementia Care for people with dementia in the community. Dr. Lyketsos is the Elizabeth Plank Althouse Professor at Johns Hopkins University. He directs the Johns Hopkins Bayview Department of Psychiatry and Behavioral Sciences, as well as the Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease and the Memory and Alzheimer’s Treatment Center. He is the recipient of multiple awards including the 2022 Argo Award for Science from the President of the Hellenic Republic. He has authored/co-authored over 450 peer-reviewed articles, chapters, commentaries, as well as five books. His work has been cited over 76,000 times with an h-index of 149. A 2021 Stanford University publication reported that he ranked #13 out of 9,246 scientists worldwide (all-time) in the field of Geriatrics. Castle-Connolly has named Dr. Lyketsos as one of America’s Top Doctors every year since 2001. A listing of Dr. Lyketsos’ publications can be found at: https://www.ncbi.nlm.nih.gov/myncbi/constantine.lyketsos.1/bibliography/public/. Dr. Lyketsos is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Dementia, Alzheimer's Disease, Lewy Body Dementia (LBD), Cerebellar Degeneration, and Deep Brain Stimulation.

Kevin Berger is a Radiologist in Catonsville, Maryland. Dr. Berger is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Vertigo, Relapsing Multiple Sclerosis (RMS), Familial Porencephaly, and Choroid Plexus Cyst.

Henry Munitz is a Radiologist in Baltimore, Maryland. Dr. Munitz is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Cerebellar Multiple System Atrophy, Hepatocerebral Degeneration, Breast Lump, and Cerebellar Degeneration.

Warren Ross is a primary care provider, practicing in Internal Medicine in Ellicott City, Maryland. Dr. Ross is rated as a Distinguished provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Cerebellar Degeneration, Inborn Amino Acid Metabolism Disorder, Anemia, and High Cholesterol. Dr. Ross is currently accepting new patients.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Dr. Jee Bang cares for patients with disorders of cognition and movement, such as Huntington disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, dementia with Lewy bodies, frontotemporal dementia, and Alzheimer disease. Dr. Bang is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. Her top areas of expertise are Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Supranuclear Ocular Palsy, and Progressive Supranuclear Palsy.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Neurologist Ashley Paul specializes in movement disorders and also serves as a clinician educator. Dr. Paul has expertise in Parkinson's Disease, atypical parkinsonism, tremors, chorea, dystonia, ataxia, restless leg syndrome, rapid eye movement sleep behavioral disorders, periodic limb movement of sleep and deep brain stimulation. She offers botulinum toxin injections for the treatment of dystonia. Dr. Paul is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. Her top areas of expertise are Movement Disorders, Drug Induced Dyskinesia, Hereditary Ataxia, and Acute Cerebellar Ataxia.

Dr. Justin McArthur is nationally and internationally recognized for his work in studying the natural history, development and treatment of the neurological complications of HIV/AIDS, multiple sclerosis and other neurological infections and immune-mediated neurological disorders. Dr. McArthur has also developed a technique to use cutaneous nerves to study sensory neuropathies, including those associated with chemotherapy, HIV and diabetes. Currently his clinical practice includes neuroimmunological disorders including MS, neurological infections, and complex undiagnosed neurological disorders. Dr. McArthur was the founding director of the Johns Hopkins/National Institute of Mental Health Research Center for HIV-associated Cognitive Disorders. The Center is an experienced interdisciplinary research team who have pooled their talents to study the nature of HIV-associated cognitive disorders. he is also the founding director of the Johns Hopkins Sheikh Khalifa Stroke institute. Dr. McArthur received his medical degree from Guys Hospital Medical School in London, UK. He then completed an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, MD. Dr. McArthur stayed with Johns Hopkins to complete a residency in neurology and achieve his Master's in public health. He is the current Director of the Johns Hopkins Department of Neurology and holds the John W. Griffin Professorship in neurology which was established in 2015 by Jeffrey and Harriet Legum. In April 2017 Dr. McArthur was elected to the Association of American Physicians. In 2020 he was inducted into the National Academy of Medicine. Dr. Mcarthur is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Encephalitis.